Hospitalization Costs and Clinical Burden of Rotavirus Gastroenteritis in Children Under Five: A Retrospective Study

Pelin Yücesan Şahin1, Gülnihan Üstündağ2, Ahu Kara Aksay2

  • 1Department of Pediatrics, Izmir Tepecik Training and Research Hospital, İzmir, Türkiye.

Clinical Pediatrics
|April 26, 2026
PubMed

Insights

Rotavirus gastroenteritis significantly impacts young children, causing hospitalizations and costs. Vaccination is not yet widespread, but rotavirus vaccine costs are lower than hospitalization expenses, suggesting cost-effectiveness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Rotavirus is a leading cause of acute gastroenteritis and hospitalization in young children globally.
  • Widespread rotavirus vaccination is not yet implemented in many regions, leaving populations vulnerable.
  • Understanding the clinical and economic burden of rotavirus gastroenteritis is crucial for public health interventions.

Purpose of the Study:

  • To evaluate the demographics, clinical outcomes, length of stay, vaccination status, and direct medical costs associated with rotavirus gastroenteritis in hospitalized children.
  • To assess the potential cost-effectiveness of rotavirus vaccination in the context of current hospitalization costs.

Main Methods:

  • Retrospective hospital-based study of children aged 1 month to 5 years with laboratory-confirmed rotavirus gastroenteritis.
  • Data collected included patient demographics, clinical presentation, treatment, length of hospital stay, and direct medical costs.
  • Analysis of vaccination status and comparison of vaccine prices with median hospitalization costs.

Main Results:

  • A total of 540 rotavirus-positive children were included; 77 were hospitalized, with a median age of 8 months.
  • The median hospital stay was 6 days, and the median hospitalization cost was $125.
  • None of the studied children had received rotavirus vaccination, and hospitalization costs were higher for stays exceeding 7 days.

Conclusions:

  • Rotavirus gastroenteritis imposes a significant clinical and economic burden on young children requiring hospitalization.
  • The cost of rotavirus vaccination is comparable to or lower than the median hospitalization costs, supporting its inclusion in national immunization programs.
  • Implementing rotavirus vaccination could be a cost-effective strategy to reduce childhood gastroenteritis burden and healthcare expenditures.

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...